Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs Inhalational Milrinone in Cardiac Surgery with PH
NCT04718350Completed
- Sponsor
- Aretaieion University Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levosimendan in pulmonary hypertension (PH) and right-sided heart failure (2 arms), sponsored by Aretaieion University Hospital. Primary endpoints: Mean Pulmonary Arterial Pressure, Pulmonary Vascular Resistance and 8 more. Started Jan 2021; status: completed.
02
Drugs
levosimendan
03
Conditions
pulmonary hypertension (PH)right-sided heart failure
Beyond the preview
Go deeper on NCT04718350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04718350.